Journal of Pharmacy and Pharmaceutical Research Open Access

  • Journal h-index: 5
  • Journal CiteScore: 0.94
  • Journal Impact Factor: 0.52
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Igor E. Kuznetsov

Department of Pharmacy, Clinical and Diagnostic Center Pharmbiotest, Kyiv, Ukraine

Publications
  • Research Article   
    Nalbuphine Nasal Spray: Analgesic Efficacy and Safety
    Author(s): Igor E. Kuznetsov* and Volodymyr G. Tymko

    Opioids are used for the treatment of moderate to severe pain that is not responsive to other analgesics. Powerful opioid analgesics (full mu-agonists), such as morphine and fentanyl, are highly effective but have multiple harmful side effects, including abuse and dependence. The decades-long search for an ‘ideal analgesic’ that provides fast pain relief for various types of pain, has long-lasting effects, is well-tolerated and can be taken orally has led to the development of biased opioid agonists providing potent pain relief with reduced side effects. These promising new medications still need extensive clinical investigation, while the potential for pharmacokinetic improvements of well-studied and long-used opioid medications remains. Nalbuphine, a mixed partial mu-receptor antagonist and kappa-receptor agonist, is as effective as morphi.. View More»

    DOI: 10.21767/ipipr.8.02.011

    Abstract HTML PDF